Stocks and Investing Stocks and Investing
Fri, June 7, 2024
Thu, June 6, 2024
Wed, June 5, 2024

Raghuram Selvaraju Reiterated (SPRB) at Hold on, Jun 5th, 2024


Published on 2024-10-28 11:47:40 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Reiterated "Spruce Biosciences, Inc." (SPRB) at Hold on, Jun 5th, 2024.

Raghuram has made no other calls on SPRB in the last 4 months.



There are 5 other peers that have a rating on SPRB. Out of the 5 peers that are also analyzing SPRB, 4 agree with Raghuram's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Aydin Huseynov of "Ladenburg Thalmann" Downgraded from Strong Buy to Hold on, Thursday, March 14th, 2024
  • Evan Wang of "Guggenheim" Downgraded from Strong Buy to Hold on, Thursday, March 14th, 2024
  • Gregory Renza of "RBC Capital" Downgraded from Buy to Hold and Decreased Target to $2 on, Thursday, March 14th, 2024
  • Joseph Schwartz of "Leerink Partners" Downgraded from Buy to Hold and Decreased Target to $2 on, Thursday, March 14th, 2024


This is the rating of the analyst that currently disagrees with Raghuram


  • Jonathan Wolleben of "JMP Securities" Maintained at Buy with Decreased Target to $3 on, Thursday, March 14th, 2024